{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "16280176", "DateCompleted": {"Year": "2006", "Month": "04", "Day": "27"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"ArticleDate": [{"Year": "2005", "Month": "10", "Day": "27"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0166-3542", "JournalIssue": {"Volume": "68", "Issue": "3", "PubDate": {"Year": "2005", "Month": "Dec"}}, "Title": "Antiviral research", "ISOAbbreviation": "Antiviral Res"}, "ArticleTitle": "A novel inhibitor of respiratory syncytial virus isolated from ethnobotanicals.", "Pagination": {"StartPage": "163", "EndPage": "172", "MedlinePgn": "163-72"}, "Abstract": {"AbstractText": ["A novel low molecular weight compound, CJ 4-16-4, isolated from ethnobotanicals using bioassay-guided fractionation, was found to be a potent inhibitor of respiratory syncytial virus (RSV) in vitro and in vivo. In vitro, a very low micromolar efficacious dose was obtained against at least four of subtype A (RSV-Long, RSV A2, and RSV A6 57754) and one of subtype B (Washington) RSV strains without seeing any significant cytotoxicity to Hep-2, MDCK or Vero cell lines. The drug inhibits growth of RSV in Hep-2 cells maintained in tissue culture at a very low concentration (approximately 0.07 microM) with cell toxicity >400 microM (TI>5880). In a cotton rat model of RSV infection, the drug was able to reduce viral titers by approximately 1 log at dose 12.5 and 25 mg/kg/day, and by >2 log at 100 mg/kg/day. This antiviral activity was specific as influenza A and B and herpes simplex 1 and 2 viruses were not inhibited. The results obtained indicate that CJ 4-16-4 warrants clinical development."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "ZymeTx, Inc., Oklahoma City, OK 73104, USA. Ojwangj@zymetx.com"}], "Identifier": [], "LastName": "Ojwang", "ForeName": "Joshua O", "Initials": "JO"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "Yan-Hong", "Initials": "YH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wyde", "ForeName": "Philip R", "Initials": "PR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fischer", "ForeName": "Nikolaus H", "Initials": "NH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Schuehly", "ForeName": "Wolfgang", "Initials": "W"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Appleman", "ForeName": "James R", "Initials": "JR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hinds", "ForeName": "Soreeta", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shimasaki", "ForeName": "Craig D", "Initials": "CD"}], "GrantList": [{"GrantID": "R43 AI46848", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R44 AI46848", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Antiviral Res", "NlmUniqueID": "8109699", "ISSNLinking": "0166-3542"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "caffeoylquinic acid"}, {"RegistryNumber": "058C04BGYI", "NameOfSubstance": "Quinic Acid"}], "MeshHeadingList": [{"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Cell Culture Techniques"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["analogs & derivatives", "isolation & purification", "pharmacology"], "DescriptorName": "Quinic Acid"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Respiratory Syncytial Virus Infections"}, {"QualifierName": ["drug effects"], "DescriptorName": "Respiratory Syncytial Viruses"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2005", "Month": "6", "Day": "30"}, {"Year": "2005", "Month": "9", "Day": "20"}, {"Year": "2005", "Month": "9", "Day": "21"}, {"Year": "2005", "Month": "11", "Day": "11", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "4", "Day": "28", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "11", "Day": "11", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["16280176", "10.1016/j.antiviral.2005.09.003", "S0166-3542(05)00195-6"]}}], "PubmedBookArticle": []}